The Khavinson
Research Legacy
Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology began researching tetrapeptide sequences derived from the pineal gland in the 1980s — a period when Western longevity science was still largely theoretical. Epithalon (also written Epitalon; Ala-Glu-Asp-Gly) was the result of this work: a synthetic analog of epithalamin, a natural peptide produced by the pineal gland.
Over four decades of research — spanning animal models, cell studies, and human clinical trials across the Russian and international scientific literature — produced a consistent body of evidence: Epithalon activates telomerase, promotes telomere elongation, modulates gene expression toward more youthful patterns, and improves markers of cellular age.
A 2025 PMC review confirmed telomere lengthening in human subjects, bringing Khavinson's four decades of findings into direct alignment with the modern telomere biology framework pioneered by Elizabeth Blackburn, Carol Greider, and Jack Szostak — the 2009 Nobel laureates who established telomere maintenance as a fundamental mechanism of cellular aging.
Mechanism of Action
Epithalon operates through three distinct and well-characterized molecular mechanisms, each targeting a different dimension of cellular aging.
Telomerase Activation
Epithalon increases expression of TERT — the catalytic subunit of telomerase, the enzyme responsible for adding telomeric repeat sequences (TTAGGG) to chromosome ends. Without adequate telomerase activity, each cell division shortens telomeres until critical length triggers senescence or apoptosis. Epithalon restores the capacity for telomere elongation, documented in multiple cell models and human subject studies.
Gene Expression Modulation
Epithalon functions as a bioregulator — a class of compounds identified by Khavinson that normalize gene expression in aging cells toward more youthful transcriptional patterns. In aging cells, gene expression drifts from developmental set-points. Epithalon's tetrapeptide sequence interacts with chromatin to partially reverse this drift, modulating hundreds of genes involved in cell cycle regulation, apoptosis resistance, and mitochondrial function.
Antioxidant Upregulation
Oxidative stress is a primary driver of telomere shortening — reactive oxygen species (ROS) directly damage telomeric DNA, which is particularly vulnerable due to its guanine-rich sequence. Epithalon increases activity of superoxide dismutase (SOD), catalase, and glutathione peroxidase — the three primary antioxidant enzymes. This reduces oxidative telomere damage and extends the functional life of existing telomere length.
Key Research Data Points
The Protocol Options
Two primary protocol structures emerge from the published literature. Both are derived from the Khavinson research tradition; the choice depends on research context and compound availability.
Standard 10-Day Cycle
The foundational protocol from Khavinson's original research. Two-per-year frequency is validated across multiple study cohorts. One 50mg vial covers a full cycle at 5mg/day.
Extended 20-Day Cycle
Preferred by researchers studying epigenetic bioregulation. The extended exposure period is hypothesized to produce deeper gene expression normalization. Less common in published clinical data than the 10-day protocol.
Dosing Details
Epithalon + NAD+
These two compounds are mechanistically complementary at a deep biological level — addressing completely separate dimensions of the cellular aging process without any receptor overlap or redundancy.
Epithalon
Structural chromosome protection via telomerase activation. Addresses the progressive shortening of telomeres that occurs with each cell division — the biological clock at the chromosomal level.
NAD+
Metabolic repair and gene expression regulation via sirtuin pathway restoration. NAD+ decline is the primary upstream cause of SIRT1/SIRT3 dysfunction — sirtuins govern hundreds of metabolic and epigenetic processes.
What Researchers Report
Across published study periods, a consistent pattern of findings emerges in the Epithalon literature. These represent documented research outcomes — not claims about individual use.
Frequently Asked Questions
Epithalon 50mg
Third-party tested, ≥98% HPLC purity, full Certificate of Analysis. One vial covers a complete standard 10-day Khavinson cycle at 5mg/day.
Source Epithalon at Apollo Peptide Sciences
Third-party tested. Certificate of Analysis on every order. The benchmark source for research-grade longevity peptides.